Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies. [electronic resource] by
- DeAngelo, D J
- Spencer, A
- Bhalla, K N
- Prince, H M
- Fischer, T
- Kindler, T
- Giles, F J
- Scott, J W
- Parker, K
- Liu, A
- Woo, M
- Atadja, P
- Mishra, K K
- Ottmann, O G
Producer: 20131021
In:
Leukemia vol. 27
Availability: No items available.
|
|
19.
|
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival. [electronic resource] by
- Lisak, D
- Schacht, T
- Gawlitza, A
- Albrecht, P
- Aktas, O
- Koop, B
- Gliem, M
- Hofstetter, H H
- Zanger, K
- Bultynck, G
- Parys, J B
- De Smedt, H
- Kindler, T
- Adams-Quack, P
- Hahn, M
- Waisman, A
- Reed, J C
- Hövelmeyer, N
- Methner, A
Producer: 20161014
In:
Cell death and differentiation vol. 23
Availability: No items available.
|
|
20.
|
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure. [electronic resource] by
- Wattad, M
- Weber, D
- Döhner, K
- Krauter, J
- Gaidzik, V I
- Paschka, P
- Heuser, M
- Thol, F
- Kindler, T
- Lübbert, M
- Salih, H R
- Kündgen, A
- Horst, H-A
- Brossart, P
- Götze, K
- Nachbaur, D
- Köhne, C-H
- Ringhoffer, M
- Wulf, G
- Held, G
- Salwender, H
- Benner, A
- Ganser, A
- Döhner, H
- Schlenk, R F
Producer: 20171017
In:
Leukemia vol. 31
Availability: No items available.
|